Jonathan Leano
About Jonathan Leano
Jonathan Leano is a Senior Scientist at Nautilus Biotechnology, specializing in the design and production of IgG monoclonal antibodies. He holds a Bachelor's degree in Biochemistry from the University of Washington and a PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill.
Work at Nautilus Biotechnology
Jonathan Leano currently holds multiple roles at Nautilus Biotechnology, including Senior Scientist, Protein Scientist, and Research Scientist II. Since 2020, he has been involved in designing and producing IgG monoclonal antibodies. His responsibilities include overseeing a research team dedicated to this area. He specializes in synthesizing IgGs identified through display screening methods and expressing them using mammalian cell cultures. Additionally, he verifies the binding of IgGs against their designed targets, contributing to the company's advancements in biotechnology.
Education and Expertise
Jonathan Leano earned a Bachelor's degree in Biochemistry from the University of Washington, where he studied from 2004 to 2008. He furthered his education at the University of North Carolina at Chapel Hill, obtaining a Doctor of Philosophy (PhD) in Biochemistry and Biophysics from 2009 to 2014. His academic background has equipped him with skills in molecular cloning and protein construct design, which he applies in his current research.
Background
Before joining Nautilus Biotechnology, Jonathan Leano worked as a Graduate Student at the University of North Carolina at Chapel Hill from 2009 to 2014. He then served as a Postdoctoral Researcher at UCSF from 2014 to 2019. His extensive research experience in these roles laid the foundation for his current position in the biotechnology sector.
Achievements
Jonathan Leano has developed expertise in X-ray crystallography and structural biology during his graduate and postdoctoral research. His training in these areas supports his current work in designing and producing monoclonal antibodies. His contributions to the field of biotechnology are evident through his specialized skills and leadership in research.